-

Carlsmed Adds Industry Veteran, Kevin O’Boyle, to Board of Directors

CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, the leader in personalized spine surgery, announced that Kevin O’Boyle has joined its Board of Directors and will serve as the Chair of the Audit Committee.

Mr. O’Boyle previously served as a director of seven publicly traded companies, including Wright Medical Group (WMGI), GenMark Diagnostics (GNMK) and Zeltiq (ZLTQ). In addition to Carlsmed, he currently serves on the board of Nevro (NVRO). Mr. O’Boyle has over 20 years of executive management experience and 14 years of board of director experience in the medical device industry.

“With his decades of financial governance expertise in the medical technology industry, Kevin is a valuable addition to our experienced Board of Directors,” states Mike Cordonnier, CEO and Chairman of Carlsmed. “The addition of Kevin to the Board is another step forward for our Company and comes on the heels of several significant accomplishments.”

In August, the Company shared that compelling clinical data was published demonstrating lower rates of revision surgery for spine surgery procedures utilizing personalized interbody devices. The special issue, “Personalized Medicine in Spine Surgery,” published by the International Journal of Spine Surgery, is available HERE.

The Company also announced that as of October 1, spine fusion procedures using its aprevo® patient-specific devices will be assigned to the highest level of Medicare Severity-Diagnosis Related Groups (MS-DRG), resulting in more favorable reimbursement on average.

According to Mr. Cordonnier, “The mounting clinical evidence in support of aprevo patient-specific solutions for spine surgery, combined with favorable reimbursement, points toward a future in which personalized spine surgery is the standard of care and the first choice for patients.”

About Carlsmed

Carlsmed is a commercial stage technology company and leader of the personalized spine surgery market. aprevo® is the only commercially available custom made anatomically designed interbody for spine fusion surgery.

Contacts

For media and investor inquiries, please contact Jodi Allen at jodi@carlsmed.com.

Industry:

Carlsmed

Release Versions
English
Hashtags
#Carlsmed
#MedicalDevice
#PersonalizedSurgery
#Spine
#SpineSurgery
#SurgicalDevice
#aprevo

Contacts

For media and investor inquiries, please contact Jodi Allen at jodi@carlsmed.com.

Social Media Profiles
LinkedIn
Twitter
More News From Carlsmed

Carlsmed Announces FDA Clearance for aprevo® Cervical Breakthrough Fusion Device

CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, Inc. (“Carlsmed” or the “Company”) a MedTech company pioneering AI-enabled personalized spine surgery, today announced FDA 510(k) clearance for the aprevo® Cervical ACDF Interbody System. This milestone underscores Carlsmed’s commitment to advancing patient-specific spine surgery solutions that enhance outcomes and surgical precision. The FDA previously granted Breakthrough Device designation for Carlsmed’s aprevo® technology for the treatment of pat...

Carlsmed Launches Cutting-Edge Digital Production Line, Revolutionizing Spine Surgery

CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, a commercial-stage medical technology company and pioneer of the personalized spine surgery market, today announced the successful launch of its state-of-the-art digital production line. This innovative technology will enable the company to deliver its aprevo® personalized spinal fusion implants to hospitals in less than ten days. “This advancement is more than just a technical achievement,” said Mike Cordonnier, Chairman and CEO of Carlsmed. “The re...

Carlsmed Announces Favorable Medicare Reimbursement Decision for Spinal Fusions with Custom-Made Anatomically Designed Devices

CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, the leader in personalized spine surgery, announced today that in the Hospital Inpatient Prospective Payment System Final Rule for fiscal year 2025, the Centers for Medicare & Medicaid Services (CMS) assigned spinal fusion cases with aprevo® custom-made anatomically designed interbody fusion devices to the highest level of the new spinal fusion Medicare Severity-Diagnosis Related Groups (MS-DRGs) it created. The new assignments and payment rates...
Back to Newsroom